About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pentoxifylline for Vascular Calcification in Kidney Disease

NCT06903689·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Dina M Gaber, M.B.B. Ch
CONTACT
+201010402101 dinamasud11@gmail.com

Lead

Mansoura University

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Estimated Glomerular Filtration Rate (eGFR) less than 60 ml/min/1.73 m² and greater than or equal to 15 ml/min/1.73 m².
Adult patients, age 18 years or older.
Diagnosis of Chronic Kidney Disease (CKD).
Willing and able to provide informed consent.

You may not be if

Patients currently undergoing regular hemodialysis.
History of kidney transplantation or are kidney transplant recipients.
Pregnant females.
Patients with a history of coronary artery bypass grafting (CABG).
Known allergy or contraindication to pentoxifylline.
Inability to comply with study procedures or attend follow-up visits.

The record

StatusNot yet recruiting

PhasePhase 1–2

Taking part80

StartedApr 2025

UpdatedApr 1, 2025

Conditions

Chronic Kidney Disease Vascular Calcification Kidney Failure, Chronic

Clareo Health | Pentoxifylline for Vascular Calcification in Kidney Disease